Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men

Journal of Lipid Research

Volumn 40, Issue 8, 1999, Pages 1467-1474

  Riemens, S C ^b   Van Tol, A ^a   Stulp, B K ^b   Dullaart, R P F ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

CETP; CETP gene; HDL cholesterol; Insulin sensitivity; LCAT; PLTP

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; INSULIN; LIPID TRANSFER PROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEINS B; BLOOD GLUCOSE; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, LDL; GLYCOPROTEINS; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; LIPOPROTEINS, VLDL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEINS; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 0032770377     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein -the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
2. Bruce, C., and A. R. Tall. 1995. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr. Opin. Lipidol. 6: 306-311.
3. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
4. Barter, P. J., and K. A. Rye. 1996. Molecular mechanisms of reverse cholesterol transport. Curr. Opin. Lipidol. 7: 82-87.
5. Tollefson, J. H., S. Ravnik, and J. J. Albers. 1988. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J. Lipid Res. 29: 1593-1602.
6. Lagrost, L., C. Desrumaux, D. Masson, V. Deckert, and P. Gambert. 1998. Structure and function of the plasma phospholipid transfer protein. Curr. Opin. Lipidol. 9: 203-209.
7. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomqvist, A. Van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
8. Tu, A. Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
9. 1-HDL. Biochim. Biophys. Acta. 1301: 255-262.
10. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1058.
11. Dullaart, R. P. F., J. E. M. Groener, and D. W. Erkelens. 1991. Cholesteryl ester transfer between lipoproteins. Diab. Nutr. Metab. 14: 329-343.
12. Taskinen, M. R., and T. Kuusi. 1987. Enzymes involved in triglyceride hydrolysis. Baillières. Clin. Endocrinol. Metab. 1: 639-666.
13. 2. J. Biol. Chem. 269: 11572-11577.
14. Reaven, G. M. 1991. Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension. Parellels between human disease and rodent models. Diabetes Care. 14: 195-202.
15. Baynes, C., A. D. Henderson, V. Anyaoku, W. Richmond, C. L. Hughes, D. G. Johnston, and R. S. Elkeles. 1991. The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of Type 2 diabetes. Diab. Med. 8: 560-566.
16. Blades, B., G. L. Vega, and S. M. Grundy. 1993. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler. Thromb. 13: 1227-1235.
17. Knudsen, P., J. Eriksson, S. Lahdenperä, J. Kahri, L. Groop, M. R. Taskinen, and the Botnia Study Group. 1995. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Diabetologia. 38: 344-350.
18. Arai, T., S. Yamashita, K. Hirano, N. Sakai, K. Kotani, S. Fujioka, S. Nozaki, Y. Keno, M. Yamane, and E. Shinohara. 1994. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler. Thromb. 14: 1129-1136.
19. Dullaart, R. P. F., W. J. Sluiter, L. D. Dikkeschei, K. Hoogenberg, and A. Van Tol. 1994. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur. J. Clin. Invest. 24: 188-194.
20. Van Tol, A., J. J. M. Ligtenberg, S. C. Riemens, T. W. Van Haeften, W. D. Reitsma, and R. P. F. Dullaart. 1997. Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scand. J. Clin. Lab. Invest. 57: 147-158.
21. Riemens, S. C., A. Van Tol, W. J. Sluiter, and R. P. F. Dullaart. 1998. Plasma phospholipid transfer protein activity is related to insulin resistance and altered free fatty acid and triglycerides: impaired acute lowering by insulin in obese Type II diabetic patients. Diabetologia. 41: 929-934.
22. Sutherland, W. H., R. J. Walker, N. J. Lewis-Barned, H. Pratt, and H. C. Tillman. 1994. The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects. Metabolism. 43: 1362-1366.
23. Arii, K., T. Suehiro, M. Yamamoto, H. Ito, and K. Hashimoto. 1997. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism. 46: 1166-1170.
24. Tall, A. R. 1992. Metabolic and genetic control of HDL cholesterol levels. J. Intern. Med. 231: 661-668.
25. Kondo, I., K. Berg, D. Drayna, and R. Lawn. 1989. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin. Genet. 35: 49-56.
26. Kuivenhoven, J. A., P. De Knijff, J. M. A. Boer, H. A. Smalheer, G. J. Botma, J. C. Seidell, J. J. P. Kastelein, and P. H. Pritchard. 1997. Heterogeneity at the CETP gene locus: influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 17: 560-568.
27. Kuivenhoven, J. A., J. W. Jukema, A. H. Zwinderman, P. De Knijff, R. McPherson, A. V. G. Bruschke, K. I. Lie, and J. J. P. Kastelein. 1998. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N. Engl. J. Med. 338: 86-93.
28. Tenkanen, H., P. Koskinen, K. Kontula, K. Aalto-Setala, M. Manttari, V. Manninen, S. L. Runeberg, M. R. Taskinen, and C. Ehnholm. 1991. Polymorphisms of the gene encoding cholesteryl ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum. Genet. 87: 574-578.
29. Fumeron, F., D. Betoulle, G. Luc, I. Behague, S. Ricard, O. Poirier, R. Jemaa, A. Evans, D. Arveiler, P. Marques-Vidal, J. M. Bard, J. C. Fruchart, P. Ducimetiere, M. Apfelbaum, and F. Cambien. 1995. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 96: 1664-1671.
30. Dullaart, R. P. F., K. Hoogenberg, L. D. Dikkeschei, and A. Van Tol. 1994. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler. Thromb. 14: 1581-1585.
31. Jones, D. Y., J. T. Judd, P. R. Taylor, W. S. Campbell, and P. P. Nair. 1988. Menstrual cycle effect on plasma lipids. Metabolism. 37: 1-2.
32. Alberti, K. G. M. M., P. Z. Zimmet, and for the WHO consultation. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diab. Med. 15: 539-553.
33. 2 cholesterol level in older adults. N. Engl. J. Med. 322: 229-234.
34. Demacker, P. N., A. G. Hijmans, H. E. Vos-Janssen, A. Van't Laar, and A. P. Jansen. 1980. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin. Chem. 26: 1775-1779.
35. Glomset, J. A., and J. L. Wright. 1964. Some properties of a cholesterol esterifying enzyme in human plasma. Biochim. Biophys. Acta. 89: 266-267.
36. Groener, J. E. M., R. W. Pelton, and G. M. Kostner. 1986. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin. Chem. 32: 283-286.
37. Hannuksela, M., Y. L. Marcel, Y. A. Kesäniemi, and M. J. Savolainen. 1992. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J. Lipid Res. 33: 737-744.
38. Floren, C. H., C. H. Chen, J. Franzen, and J. J. Albers. 1987. Lecithin: cholesterol acyltransferase in liver disease. Scand. J. Clin. Lab. Invest. 47: 613-617.
39. Speijer, H., J. E. M. Groener, E. Van Ramshorst, and A. Van Tol. 1991. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis. 90: 159-168.
40. Jansen, H., W. Hop, A. Van Tol, A. V. G. Bruschke, and J. C. Birkenhager. 1994. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease. Atherosclerosis. 107: 45-54.
41. Dullaart, R. P. F., K. Hoogenberg, S. C. Riemens, J. E. Groener, A. Van Tol, W. J. Sluiter, and B. K. Stulp. 1997. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes. Diabetes. 46: 2082-2087.
42. Laakso, M., H. Sarlund, and I,. Mykkanen. 1990. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis. 10: 223-231.
43. Reaven, G. M., Y. D. Chen, J. Jeppesen, P. Maheux, and R. M. Krauss. 1993. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J. Clin. Invest. 92: 141-146.
44. Lamarche, B., J. P. Després, M. C. Pouliot, D. Prud'homme, S. Moorjani, P. J. Lupien, A. Nadeau, A. Tremblay, and C. Bouchard. 1993. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler. Thromb. 13: 33-40.
45. Riemens, S. C., A. Van Tol, W. J. Sluiter, and R. P. F. Dullaart. 1998. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis. 140: 71-79.
46. Reaven, G. M. 1988. Role of insulin resistance in human disease. Diabetes. 37: 1595-1607.
47. Frayn, K. N., and S. W. Coppack. 1992. Insulin resistance, adipose tissue and coronary heart disease. Clin. Sci. 82: 1-8.
48. Norum, K. R. 1973. The role of lecithin:choleslerol acyl transferase in the metabolism of plasma lipoproteins. Ann. Biol. Clin. 31: 123-125.
49. Norby, G., and K. R. Norum. 1978. Aspects of the role of lecithin:cholesterol acyltransferase in metabolism of triglycerides. Scand. J. Clin. Lab. Invest. 38, Suppl 150: 111-114.
50. Syvänne, M., G. Castro, C. Dengremont, C. De Geitere, M. Jauhiainen, C. Ehnholm, S. Michelagnoli, G. Franceschini, J. Kahri, and M. R. Taskinen. 1996. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer assay. Atherosclerosis. 127: 245-253.
51. Elchebly, M., T. Pulcini, B. Porokhov, F. Berthezène, and G. Ponsin. 1996. Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes. Eur. J. Clin. Invest. 26: 216-223.
52. Martin, R. J., P. W. Cornelly, D. Nancoo, N. Wood, L. J. Zhang, G. Maguire, E. Quinet, A. R. Tall, Y. L. Marcel, and R. McPherson. 1993. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J. Lipid. Res. 34: 437-446.
53. Radeau, T., M. Robb, P. Lau, J. Borthwick, and R. McPherson. 1998. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis. 139: 369-376.
54. Freeman, D. J., B. A. Griffin, A. P. Holmes, G. M. Lindsay, D. Gaffney, C. J. Packard, and J. Shepherd. 1994. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler. Thromb. 14: 336-344.
55. Day, J. R., J. J. Albers, C. E. Lofton-Day, T. L. Gilbert, A. F. T. Ching, F. J. Grant, P. J. O'Hara, S. M. Marcovina, and J. L. Adolphson. 1994. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J. Biol. Chem. 269: 9388-9391.
56. Fan, J., J. Wang, A. Bensadoun, S. J. Lauer, Q. Dang, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91: 8724-8728.
57. Jansen, H., A. Van Tol, and W. C. Hulsmann. 1980. On the metabolic function of heparin-releasable liver lipase. Biochem. Biophys. Res. Commun. 92: 53-59.
58. Busch, S. J., R. L. Barnhart, G. A. Martin, M. C. Fitzgerald, M. T. Yates, S. J. T. Mao, C. E. Thomas, and R. L. Jackson. 1994. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 269: 16376-16382.
59. Hegele, R. A., J. A. Little, C. Vezina, G. F. Maguire, L. Tu, T. S. Wolever, D. J. A. Jenkins, and P. W. Connelly. 1993. Hepatic lipase deficiency. Clinical, biochemical and molecular genetic characteristics. Arterioscler. Thromb. 13: 720-728.
60. Hoeg, J. M., S. Santamarina-Fojo, A. M. Berard, J. F. Cornhill, E. E. Herderick, S. H. Feldman, C. C. Haudenschild, B. L. Vaisman, R. F. Hoyt, S. J. Demosky, R. D. Kauffman, C. M. Hazel, S. M. Marcovina, and H. B. Brewer. 1996. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. USA. 93: 11448-11453.
61. Bérard, A. M., B. Föger, A. Remaley, R. Shamburek, B. L. Vaisman, G. Talley, B. Paigen, R. F. Hoyt, S. Marcovina, H. B. Brewer, and S. Santamarina-Fojo. 1998. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nature Med. 3: 744-749.
62. Jiang, X., O. L. Francone, C. Bruce, R. Milne, J. Mar, A. Walsh, J. L. Breslow, and A. R. Tall. 1996. Increased preβ-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J. Clin. Invest. 96: 2373-2380.
63. Van Haperen, R., A. Van Tol, and B. Vermeulen. 1998. Human plasma phospholipid transfer protein is a potential antiatherogenic factor. A study in transgenic mice. Circulation. 98, Suppl I: 664.